Full name
CENTRALA FARMACEUTYCZNA "CEFARM" SPÓŁKA AKCYJNA
uses securityreCAPTCHA
CENTRALA FARMACEUTYCZNA "CEFARM" SPÓŁKA AKCYJNA
UL. JANA KAZIMIERZA 16, 01-248 WARSZAWA
TAX ID5250004220
Rate company:
CENTRALA FARMACEUTYCZNA "CEFARM" SPÓŁKA AKCYJNA
TAX ID5250004220
KRS0000154178
Share capital55,400,000.00 zł
address
UL. JANA KAZIMIERZA 16, 01-248 WARSZAWA
Website
www.cefarm.com.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5250004220
REGON
000288343
KRS
0000154178
Legal form
joint stock company
Register Address
UL. JANA KAZIMIERZA 16, 01-248 WARSZAWA
Date of registration in KRS
2003-03-13
Date of commencement of economic activity
2003-03-13
Act signature
WA.XIII NS-REJ.KRS/38532/23/870
Website
WWW.CEFARM.COM.PL
Pkd codes
46.46.Z - Wholesale of pharmaceutical goods
46.45.Z - Wholesale of perfume and cosmetics
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
49.41.Z - Freight transport by road
52.10.B - Warehousing and storage of other goods
52.24.C - Cargo handling in other reloading points
52.29.C - Other transportation agencies activities
68.20.Z - Rental and operating of own or leased real estate
82.92.Z - Packaging activities
Financial data
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 4,6 | 5,1 | 6,6 | 29,1 |
EBITDA | 6,2 | 5,4 | 4,7 | -13,6 |
Short time liabilities | 212 | 278,1 | 309,3 | 11,2 |
Equity capital | 79,2 | 82,2 | 86,4 | 5,1 |
Operating profit (EBIT) | 4,5 | 3,8 | 3,1 | -17,2 |
Assets | 294,6 | 363,8 | 399 | 9,7 |
Net profit (loss) | 3,6 | 3,9 | 5,2 | 31,6 |
Cash | 29,5 | 75,9 | 62,3 | -17,9 |
Net income from sale | 1086,6 | 1180,3 | 1276,2 | 8,1 |
Liabilities and provisions for liabilities | 215,4 | 281,6 | 312,6 | 11 |
Working assets | 283,8 | 354,5 | 376,7 | 6,2 |
Depreciation | 1,8 | 1,7 | 1,6 | -5,6 |
% | % | % | p.p. | |
Profitability of capital | 4,5 | 4,8 | 6 | 1,2 |
Equity capital to total assets | 26,9 | 22,6 | 21,7 | -0,9 |
Gross profit margin | 0,4 | 0,4 | 0,5 | 0,1 |
EBITDA Margin | 0,6 | 0,5 | 0,4 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 71 | 86 | 88 | 2 |
Financial statements
01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Annual financial report
Download docx01-01-2022 - 31-12-2022
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Activity report
Download pdf01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Bardomed sp. z o.o.
Kraków
"FARMEDICA" sp. z o.o.
Warszawa
Damian Poprawa LABFUNK
Kluczbork
Emprime sp. z o.o.
Sękocin Nowy
VITAMIN CLINIC WROCŁAW
Wrocław